Cellectis to Hold Third Quarter and First Nine Months 2019 Earnings Call on Thursday, November 7, 2019 at 8:00 AM EST
Published on October 31, 2019 in New York (N.Y.)
October 31, 2019 – New York – Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on allogeneic gene-edited CAR T-cells (UCART), announced that it will report third quarter 2019 financial results on Wednesday, November 6, 2019, after the close of the US market. The announcement will be followed by a conference call at 8:00 AM EST / 2:00 PM CET on Thursday, November 7, 2019, prior to the open of the US market. The company is initiating investor calls accompanying its quarterly results.
The live dial-in information for the conference call is:
US & Canada only: 877-407-3104
International: 201-493-6792
In addition, a replay of the call will be available until November 21, 2019 by calling 877-660-6853 (Toll Free US & Canada); 201-612-7415 (Toll Free International), Conference ID: 13688263